TapewireFind a company

person · Reporting owner

Curnes Nelson Bunker

Disclosed activity across 1 company

Tapewire entity
39260
SEC CIK
0002124944

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
Mobia Medical, Inc.MOBI · Entity 5669Chief Financial OfficerFebruary 23, 2026June 11, 2026

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

Mobia Medical, Inc.

Report date February 23, 2026 · Filed June 11, 2026

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeIndirectBy Exceller Hunt Microtransponder 2017, LP560,068 Reported balance After 2026-02-23 transaction · row 1 Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source row

Row 1 · 2026-02-23 · Other · Disposed 249,750 · Balance 560,068

F1: This transaction occurred prior to the Issuer's registration of a class of equity securities under Section 12 of the Securities Exchange Act of 1934, as amended, in connection with the Issuer's initial public offering and is reported pursuant to Rule 16a-2(a).

F2: Prior to the Issuer's initial public offering on May 7, 2026, the Curnes Fund 2001 and the Exceller Hunt Microtransponder 2017, LP distributed 175,077 and 249,750 shares of the Issuer's common stock, respectively, to their members (the "Distributions"). The Reporting Person received 58,359 shares of common stock in the Distributions. The Reporting Person's prior Form 3, dated May 7, 2026 and Form 4, dated May 11, 2026, inadvertently reported ownership prior to the Distributions. This Form 4 has been updated to reflect the Reporting Person's ownership following the Distributions. All shares in the Distributions remain subject to the lock-up restrictions implemented in connection with the initial public offering.

Common StockSEC Table I · non-derivativeIndirectBy Curnes Fund 20010 Reported balance After 2026-02-23 transaction · row 2 Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source row

Row 2 · 2026-02-23 · Other · Disposed 175,077 · Balance 0

F1: This transaction occurred prior to the Issuer's registration of a class of equity securities under Section 12 of the Securities Exchange Act of 1934, as amended, in connection with the Issuer's initial public offering and is reported pursuant to Rule 16a-2(a).

F2: Prior to the Issuer's initial public offering on May 7, 2026, the Curnes Fund 2001 and the Exceller Hunt Microtransponder 2017, LP distributed 175,077 and 249,750 shares of the Issuer's common stock, respectively, to their members (the "Distributions"). The Reporting Person received 58,359 shares of common stock in the Distributions. The Reporting Person's prior Form 3, dated May 7, 2026 and Form 4, dated May 11, 2026, inadvertently reported ownership prior to the Distributions. This Form 4 has been updated to reflect the Reporting Person's ownership following the Distributions. All shares in the Distributions remain subject to the lock-up restrictions implemented in connection with the initial public offering.

Common StockSEC Table I · non-derivativeDirect366,997 Reported balance After 2026-06-09 transaction · row 3 Account or security details depend on footnotes; rows are not merged.
1 source row

Row 3 · 2026-06-09 · Purchase · Acquired 5,000 · Balance 366,997

F3: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $12.65 to $13.01. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the SEC Staff, upon request, full information regarding the number of shares purchased at each price within the range set forth above.

F4: Includes 58,359 shares acquired in a pro rata distribution in kind, which was exempt from reporting pursuant to Rule 16a-13.

Common StockSEC Table I · non-derivativeIndirectBy Family Trusts5,742 Reported balance Holding disclosure · report date 2026-02-23 · row 4 Holding and transaction disclosures are not merged.
1 source row

Row 4 · Balance 5,742

Filing footnotes · ownership attribution and instrument terms

F1: This transaction occurred prior to the Issuer's registration of a class of equity securities under Section 12 of the Securities Exchange Act of 1934, as amended, in connection with the Issuer's initial public offering and is reported pursuant to Rule 16a-2(a).

F2: Prior to the Issuer's initial public offering on May 7, 2026, the Curnes Fund 2001 and the Exceller Hunt Microtransponder 2017, LP distributed 175,077 and 249,750 shares of the Issuer's common stock, respectively, to their members (the "Distributions"). The Reporting Person received 58,359 shares of common stock in the Distributions. The Reporting Person's prior Form 3, dated May 7, 2026 and Form 4, dated May 11, 2026, inadvertently reported ownership prior to the Distributions. This Form 4 has been updated to reflect the Reporting Person's ownership following the Distributions. All shares in the Distributions remain subject to the lock-up restrictions implemented in connection with the initial public offering.

F3: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $12.65 to $13.01. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the SEC Staff, upon request, full information regarding the number of shares purchased at each price within the range set forth above.

F4: Includes 58,359 shares acquired in a pro rata distribution in kind, which was exempt from reporting pursuant to Rule 16a-13.

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
June 09, 2026 Filed Jun 11, 2026 23:10 UTC Mobia Medical, Inc. MOBI · Entity 5669 PurchaseCommon Stock 5,000 $12.79 $63,969.00
Disclosure

SEC source: 0001193125-26-268109 · ownership.xml · nonDerivative · entry 3

Curnes Nelson Bunker · CIK 0002124944 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 366,997

F3 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $12.65 to $13.01. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the SEC Staff, upon request, full information regarding the number of shares purchased at each price within the range set forth above.

F4 · balance_after: Includes 58,359 shares acquired in a pro rata distribution in kind, which was exempt from reporting pursuant to Rule 16a-13.

Read SEC document
May 11, 2026 Filed May 12, 2026 01:36 UTC Mobia Medical, Inc. MOBI · Entity 5669 ConversionConvertible Notes · Derivative 4,000,000 Not disclosed Not disclosed
Disclosure

SEC source: 0001628280-26-033804 · wk-form4_1778549766.xml · derivative · entry 25

Curnes Nelson Bunker · CIK 0002124944 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Indirect · By Exceller Hunt Microtransponder 2017, LP

Disclosed balance after: 0

Underlying: Common Stock · 333,333 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: The Convertible Notes automatically converted into Common Stock immediately prior to the closing of the Offering. The conversion price is the lower of (a) 80% of the Offering price per share and (b) the valuation of the Issuer immediately prior to the closing of the Offering divided by the number of fully diluted shares of capital stock (on an as-converted basis) outstanding immediately prior to Offering, excluding the Convertible Notes.

F2 · price: The Convertible Notes automatically converted into Common Stock immediately prior to the closing of the Offering. The conversion price is the lower of (a) 80% of the Offering price per share and (b) the valuation of the Issuer immediately prior to the closing of the Offering divided by the number of fully diluted shares of capital stock (on an as-converted basis) outstanding immediately prior to Offering, excluding the Convertible Notes.

F2 · derivative.exercise_date: The Convertible Notes automatically converted into Common Stock immediately prior to the closing of the Offering. The conversion price is the lower of (a) 80% of the Offering price per share and (b) the valuation of the Issuer immediately prior to the closing of the Offering divided by the number of fully diluted shares of capital stock (on an as-converted basis) outstanding immediately prior to Offering, excluding the Convertible Notes.

F2 · derivative.expiration_date: The Convertible Notes automatically converted into Common Stock immediately prior to the closing of the Offering. The conversion price is the lower of (a) 80% of the Offering price per share and (b) the valuation of the Issuer immediately prior to the closing of the Offering divided by the number of fully diluted shares of capital stock (on an as-converted basis) outstanding immediately prior to Offering, excluding the Convertible Notes.

Read SEC document
May 11, 2026 Filed May 12, 2026 01:36 UTC Mobia Medical, Inc. MOBI · Entity 5669 ConversionConvertible Notes · Derivative 2,100,937.62 Not disclosed Not disclosed
Disclosure

SEC source: 0001628280-26-033804 · wk-form4_1778549766.xml · derivative · entry 24

Curnes Nelson Bunker · CIK 0002124944 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Indirect · By Curnes Fund 2001

Disclosed balance after: 0

Underlying: Common Stock · 175,077 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: The Convertible Notes automatically converted into Common Stock immediately prior to the closing of the Offering. The conversion price is the lower of (a) 80% of the Offering price per share and (b) the valuation of the Issuer immediately prior to the closing of the Offering divided by the number of fully diluted shares of capital stock (on an as-converted basis) outstanding immediately prior to Offering, excluding the Convertible Notes.

F2 · price: The Convertible Notes automatically converted into Common Stock immediately prior to the closing of the Offering. The conversion price is the lower of (a) 80% of the Offering price per share and (b) the valuation of the Issuer immediately prior to the closing of the Offering divided by the number of fully diluted shares of capital stock (on an as-converted basis) outstanding immediately prior to Offering, excluding the Convertible Notes.

F2 · derivative.exercise_date: The Convertible Notes automatically converted into Common Stock immediately prior to the closing of the Offering. The conversion price is the lower of (a) 80% of the Offering price per share and (b) the valuation of the Issuer immediately prior to the closing of the Offering divided by the number of fully diluted shares of capital stock (on an as-converted basis) outstanding immediately prior to Offering, excluding the Convertible Notes.

F2 · derivative.expiration_date: The Convertible Notes automatically converted into Common Stock immediately prior to the closing of the Offering. The conversion price is the lower of (a) 80% of the Offering price per share and (b) the valuation of the Issuer immediately prior to the closing of the Offering divided by the number of fully diluted shares of capital stock (on an as-converted basis) outstanding immediately prior to Offering, excluding the Convertible Notes.

Read SEC document
May 11, 2026 Filed May 12, 2026 01:36 UTC Mobia Medical, Inc. MOBI · Entity 5669 OtherWarrants · Derivative 24,000 Not disclosed Strike: $14.65 Not disclosed
Disclosure

SEC source: 0001628280-26-033804 · wk-form4_1778549766.xml · derivative · entry 23

Curnes Nelson Bunker · CIK 0002124944 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 6,794 shares

Expires 2033-05-24

F5 · price: The warrants are currently exercisable. In connection with the Offering, the warrants were exercised according to the terms of the applicable warrant agreement. The warrants have a net exercise provision under which the Reporting Person may, in lieu of payment of the exercise price in cash, surrender the warrants and receive a net amount of shares based on the fair market value of the shares at the time of exercise of the warrants after deduction of the aggregate exercise price.

F5 · derivative.exercise_date: The warrants are currently exercisable. In connection with the Offering, the warrants were exercised according to the terms of the applicable warrant agreement. The warrants have a net exercise provision under which the Reporting Person may, in lieu of payment of the exercise price in cash, surrender the warrants and receive a net amount of shares based on the fair market value of the shares at the time of exercise of the warrants after deduction of the aggregate exercise price.

Read SEC document
May 11, 2026 Filed May 12, 2026 01:36 UTC Mobia Medical, Inc. MOBI · Entity 5669 OtherWarrants · Derivative 23,666 Not disclosed Strike: $14.65 Not disclosed
Disclosure

SEC source: 0001628280-26-033804 · wk-form4_1778549766.xml · derivative · entry 22

Curnes Nelson Bunker · CIK 0002124944 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 6,890 shares

Expires 2033-06-13

F5 · price: The warrants are currently exercisable. In connection with the Offering, the warrants were exercised according to the terms of the applicable warrant agreement. The warrants have a net exercise provision under which the Reporting Person may, in lieu of payment of the exercise price in cash, surrender the warrants and receive a net amount of shares based on the fair market value of the shares at the time of exercise of the warrants after deduction of the aggregate exercise price.

F5 · derivative.exercise_date: The warrants are currently exercisable. In connection with the Offering, the warrants were exercised according to the terms of the applicable warrant agreement. The warrants have a net exercise provision under which the Reporting Person may, in lieu of payment of the exercise price in cash, surrender the warrants and receive a net amount of shares based on the fair market value of the shares at the time of exercise of the warrants after deduction of the aggregate exercise price.

Read SEC document
May 11, 2026 Filed May 12, 2026 01:36 UTC Mobia Medical, Inc. MOBI · Entity 5669 ConversionSeries F Preferred Stock · Derivative 285,846 Not disclosed Not disclosed
Disclosure

SEC source: 0001628280-26-033804 · wk-form4_1778549766.xml · derivative · entry 21

Curnes Nelson Bunker · CIK 0002124944 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Indirect · By Exceller Hunt Microtransponder 2017, LP

Disclosed balance after: 0

Underlying: Common Stock · 82,068 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each share of the Series A, Series C, Series D, Series E-1, Series E-2 and Series F Preferred Stock converted into Common Stock immediately prior to the completion of the Issuer's initial public offering (the "Offering") pursuant to its terms.

F1 · price: Each share of the Series A, Series C, Series D, Series E-1, Series E-2 and Series F Preferred Stock converted into Common Stock immediately prior to the completion of the Issuer's initial public offering (the "Offering") pursuant to its terms.

F1 · derivative.exercise_date: Each share of the Series A, Series C, Series D, Series E-1, Series E-2 and Series F Preferred Stock converted into Common Stock immediately prior to the completion of the Issuer's initial public offering (the "Offering") pursuant to its terms.

F1 · derivative.expiration_date: Each share of the Series A, Series C, Series D, Series E-1, Series E-2 and Series F Preferred Stock converted into Common Stock immediately prior to the completion of the Issuer's initial public offering (the "Offering") pursuant to its terms.

Read SEC document
May 11, 2026 Filed May 12, 2026 01:36 UTC Mobia Medical, Inc. MOBI · Entity 5669 ConversionSeries E-2 Preferred Stock · Derivative 596,219 Not disclosed Not disclosed
Disclosure

SEC source: 0001628280-26-033804 · wk-form4_1778549766.xml · derivative · entry 20

Curnes Nelson Bunker · CIK 0002124944 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Indirect · By Exceller Hunt Microtransponder 2017, LP

Disclosed balance after: 0

Underlying: Common Stock · 171,179 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each share of the Series A, Series C, Series D, Series E-1, Series E-2 and Series F Preferred Stock converted into Common Stock immediately prior to the completion of the Issuer's initial public offering (the "Offering") pursuant to its terms.

F1 · price: Each share of the Series A, Series C, Series D, Series E-1, Series E-2 and Series F Preferred Stock converted into Common Stock immediately prior to the completion of the Issuer's initial public offering (the "Offering") pursuant to its terms.

F1 · derivative.exercise_date: Each share of the Series A, Series C, Series D, Series E-1, Series E-2 and Series F Preferred Stock converted into Common Stock immediately prior to the completion of the Issuer's initial public offering (the "Offering") pursuant to its terms.

F1 · derivative.expiration_date: Each share of the Series A, Series C, Series D, Series E-1, Series E-2 and Series F Preferred Stock converted into Common Stock immediately prior to the completion of the Issuer's initial public offering (the "Offering") pursuant to its terms.

Read SEC document
May 11, 2026 Filed May 12, 2026 01:36 UTC Mobia Medical, Inc. MOBI · Entity 5669 ConversionSeries E-1 Preferred Stock · Derivative 272,271 Not disclosed Not disclosed
Disclosure

SEC source: 0001628280-26-033804 · wk-form4_1778549766.xml · derivative · entry 19

Curnes Nelson Bunker · CIK 0002124944 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Indirect · By Exceller Hunt Microtransponder 2017, LP

Disclosed balance after: 0

Underlying: Common Stock · 78,171 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each share of the Series A, Series C, Series D, Series E-1, Series E-2 and Series F Preferred Stock converted into Common Stock immediately prior to the completion of the Issuer's initial public offering (the "Offering") pursuant to its terms.

F1 · price: Each share of the Series A, Series C, Series D, Series E-1, Series E-2 and Series F Preferred Stock converted into Common Stock immediately prior to the completion of the Issuer's initial public offering (the "Offering") pursuant to its terms.

F1 · derivative.exercise_date: Each share of the Series A, Series C, Series D, Series E-1, Series E-2 and Series F Preferred Stock converted into Common Stock immediately prior to the completion of the Issuer's initial public offering (the "Offering") pursuant to its terms.

F1 · derivative.expiration_date: Each share of the Series A, Series C, Series D, Series E-1, Series E-2 and Series F Preferred Stock converted into Common Stock immediately prior to the completion of the Issuer's initial public offering (the "Offering") pursuant to its terms.

Read SEC document
May 11, 2026 Filed May 12, 2026 01:36 UTC Mobia Medical, Inc. MOBI · Entity 5669 ConversionSeries D Preferred Stock · Derivative 505,269 Not disclosed Not disclosed
Disclosure

SEC source: 0001628280-26-033804 · wk-form4_1778549766.xml · derivative · entry 18

Curnes Nelson Bunker · CIK 0002124944 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Indirect · By Exceller Hunt Microtransponder 2017, LP

Disclosed balance after: 0

Underlying: Common Stock · 145,067 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each share of the Series A, Series C, Series D, Series E-1, Series E-2 and Series F Preferred Stock converted into Common Stock immediately prior to the completion of the Issuer's initial public offering (the "Offering") pursuant to its terms.

F1 · price: Each share of the Series A, Series C, Series D, Series E-1, Series E-2 and Series F Preferred Stock converted into Common Stock immediately prior to the completion of the Issuer's initial public offering (the "Offering") pursuant to its terms.

F1 · derivative.exercise_date: Each share of the Series A, Series C, Series D, Series E-1, Series E-2 and Series F Preferred Stock converted into Common Stock immediately prior to the completion of the Issuer's initial public offering (the "Offering") pursuant to its terms.

F1 · derivative.expiration_date: Each share of the Series A, Series C, Series D, Series E-1, Series E-2 and Series F Preferred Stock converted into Common Stock immediately prior to the completion of the Issuer's initial public offering (the "Offering") pursuant to its terms.

Read SEC document
May 11, 2026 Filed May 12, 2026 01:36 UTC Mobia Medical, Inc. MOBI · Entity 5669 ConversionSeries C Preferred Stock · Derivative 20,000 Not disclosed Not disclosed
Disclosure

SEC source: 0001628280-26-033804 · wk-form4_1778549766.xml · derivative · entry 17

Curnes Nelson Bunker · CIK 0002124944 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Indirect · By Family Trusts

Disclosed balance after: 0

Underlying: Common Stock · 5,742 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each share of the Series A, Series C, Series D, Series E-1, Series E-2 and Series F Preferred Stock converted into Common Stock immediately prior to the completion of the Issuer's initial public offering (the "Offering") pursuant to its terms.

F1 · price: Each share of the Series A, Series C, Series D, Series E-1, Series E-2 and Series F Preferred Stock converted into Common Stock immediately prior to the completion of the Issuer's initial public offering (the "Offering") pursuant to its terms.

F1 · derivative.exercise_date: Each share of the Series A, Series C, Series D, Series E-1, Series E-2 and Series F Preferred Stock converted into Common Stock immediately prior to the completion of the Issuer's initial public offering (the "Offering") pursuant to its terms.

F1 · derivative.expiration_date: Each share of the Series A, Series C, Series D, Series E-1, Series E-2 and Series F Preferred Stock converted into Common Stock immediately prior to the completion of the Issuer's initial public offering (the "Offering") pursuant to its terms.

Read SEC document
May 11, 2026 Filed May 12, 2026 01:36 UTC Mobia Medical, Inc. MOBI · Entity 5669 ConversionSeries F Preferred Stock · Derivative 284,986 Not disclosed Not disclosed
Disclosure

SEC source: 0001628280-26-033804 · wk-form4_1778549766.xml · derivative · entry 16

Curnes Nelson Bunker · CIK 0002124944 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 81,821 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each share of the Series A, Series C, Series D, Series E-1, Series E-2 and Series F Preferred Stock converted into Common Stock immediately prior to the completion of the Issuer's initial public offering (the "Offering") pursuant to its terms.

F1 · price: Each share of the Series A, Series C, Series D, Series E-1, Series E-2 and Series F Preferred Stock converted into Common Stock immediately prior to the completion of the Issuer's initial public offering (the "Offering") pursuant to its terms.

F1 · derivative.exercise_date: Each share of the Series A, Series C, Series D, Series E-1, Series E-2 and Series F Preferred Stock converted into Common Stock immediately prior to the completion of the Issuer's initial public offering (the "Offering") pursuant to its terms.

F1 · derivative.expiration_date: Each share of the Series A, Series C, Series D, Series E-1, Series E-2 and Series F Preferred Stock converted into Common Stock immediately prior to the completion of the Issuer's initial public offering (the "Offering") pursuant to its terms.

Read SEC document
May 11, 2026 Filed May 12, 2026 01:36 UTC Mobia Medical, Inc. MOBI · Entity 5669 ConversionSeries E-1 Preferred Stock · Derivative 29,168 Not disclosed Not disclosed
Disclosure

SEC source: 0001628280-26-033804 · wk-form4_1778549766.xml · derivative · entry 15

Curnes Nelson Bunker · CIK 0002124944 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 8,374 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each share of the Series A, Series C, Series D, Series E-1, Series E-2 and Series F Preferred Stock converted into Common Stock immediately prior to the completion of the Issuer's initial public offering (the "Offering") pursuant to its terms.

F1 · price: Each share of the Series A, Series C, Series D, Series E-1, Series E-2 and Series F Preferred Stock converted into Common Stock immediately prior to the completion of the Issuer's initial public offering (the "Offering") pursuant to its terms.

F1 · derivative.exercise_date: Each share of the Series A, Series C, Series D, Series E-1, Series E-2 and Series F Preferred Stock converted into Common Stock immediately prior to the completion of the Issuer's initial public offering (the "Offering") pursuant to its terms.

F1 · derivative.expiration_date: Each share of the Series A, Series C, Series D, Series E-1, Series E-2 and Series F Preferred Stock converted into Common Stock immediately prior to the completion of the Issuer's initial public offering (the "Offering") pursuant to its terms.

Read SEC document
May 11, 2026 Filed May 12, 2026 01:36 UTC Mobia Medical, Inc. MOBI · Entity 5669 ConversionSeries D Preferred Stock · Derivative 383,333 Not disclosed Not disclosed
Disclosure

SEC source: 0001628280-26-033804 · wk-form4_1778549766.xml · derivative · entry 14

Curnes Nelson Bunker · CIK 0002124944 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 110,058 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each share of the Series A, Series C, Series D, Series E-1, Series E-2 and Series F Preferred Stock converted into Common Stock immediately prior to the completion of the Issuer's initial public offering (the "Offering") pursuant to its terms.

F1 · price: Each share of the Series A, Series C, Series D, Series E-1, Series E-2 and Series F Preferred Stock converted into Common Stock immediately prior to the completion of the Issuer's initial public offering (the "Offering") pursuant to its terms.

F1 · derivative.exercise_date: Each share of the Series A, Series C, Series D, Series E-1, Series E-2 and Series F Preferred Stock converted into Common Stock immediately prior to the completion of the Issuer's initial public offering (the "Offering") pursuant to its terms.

F1 · derivative.expiration_date: Each share of the Series A, Series C, Series D, Series E-1, Series E-2 and Series F Preferred Stock converted into Common Stock immediately prior to the completion of the Issuer's initial public offering (the "Offering") pursuant to its terms.

Read SEC document
May 11, 2026 Filed May 12, 2026 01:36 UTC Mobia Medical, Inc. MOBI · Entity 5669 ConversionSeries C Preferred Stock · Derivative 100,000 Not disclosed Not disclosed
Disclosure

SEC source: 0001628280-26-033804 · wk-form4_1778549766.xml · derivative · entry 13

Curnes Nelson Bunker · CIK 0002124944 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 28,710 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each share of the Series A, Series C, Series D, Series E-1, Series E-2 and Series F Preferred Stock converted into Common Stock immediately prior to the completion of the Issuer's initial public offering (the "Offering") pursuant to its terms.

F1 · price: Each share of the Series A, Series C, Series D, Series E-1, Series E-2 and Series F Preferred Stock converted into Common Stock immediately prior to the completion of the Issuer's initial public offering (the "Offering") pursuant to its terms.

F1 · derivative.exercise_date: Each share of the Series A, Series C, Series D, Series E-1, Series E-2 and Series F Preferred Stock converted into Common Stock immediately prior to the completion of the Issuer's initial public offering (the "Offering") pursuant to its terms.

F1 · derivative.expiration_date: Each share of the Series A, Series C, Series D, Series E-1, Series E-2 and Series F Preferred Stock converted into Common Stock immediately prior to the completion of the Issuer's initial public offering (the "Offering") pursuant to its terms.

Read SEC document
May 11, 2026 Filed May 12, 2026 01:36 UTC Mobia Medical, Inc. MOBI · Entity 5669 ConversionSeries A Preferred Stock · Derivative 191,330 Not disclosed Not disclosed
Disclosure

SEC source: 0001628280-26-033804 · wk-form4_1778549766.xml · derivative · entry 12

Curnes Nelson Bunker · CIK 0002124944 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 54,932 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each share of the Series A, Series C, Series D, Series E-1, Series E-2 and Series F Preferred Stock converted into Common Stock immediately prior to the completion of the Issuer's initial public offering (the "Offering") pursuant to its terms.

F1 · price: Each share of the Series A, Series C, Series D, Series E-1, Series E-2 and Series F Preferred Stock converted into Common Stock immediately prior to the completion of the Issuer's initial public offering (the "Offering") pursuant to its terms.

F1 · derivative.exercise_date: Each share of the Series A, Series C, Series D, Series E-1, Series E-2 and Series F Preferred Stock converted into Common Stock immediately prior to the completion of the Issuer's initial public offering (the "Offering") pursuant to its terms.

F1 · derivative.expiration_date: Each share of the Series A, Series C, Series D, Series E-1, Series E-2 and Series F Preferred Stock converted into Common Stock immediately prior to the completion of the Issuer's initial public offering (the "Offering") pursuant to its terms.

Read SEC document
May 11, 2026 Filed May 12, 2026 01:36 UTC Mobia Medical, Inc. MOBI · Entity 5669 ConversionCommon Stock 175,077 Not disclosed Not disclosed
Disclosure

SEC source: 0001628280-26-033804 · wk-form4_1778549766.xml · nonDerivative · entry 7

Curnes Nelson Bunker · CIK 0002124944 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Indirect · By Curnes Fund 2001

Disclosed balance after: 175,077

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · price: The Convertible Notes automatically converted into Common Stock immediately prior to the closing of the Offering. The conversion price is the lower of (a) 80% of the Offering price per share and (b) the valuation of the Issuer immediately prior to the closing of the Offering divided by the number of fully diluted shares of capital stock (on an as-converted basis) outstanding immediately prior to Offering, excluding the Convertible Notes.

Read SEC document
May 11, 2026 Filed May 12, 2026 01:36 UTC Mobia Medical, Inc. MOBI · Entity 5669 ConversionCommon Stock 333,333 Not disclosed Not disclosed
Disclosure

SEC source: 0001628280-26-033804 · wk-form4_1778549766.xml · nonDerivative · entry 6

Curnes Nelson Bunker · CIK 0002124944 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Indirect · By Exceller Hunt Microtransponder 2017, LP

Disclosed balance after: 809,818

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · price: The Convertible Notes automatically converted into Common Stock immediately prior to the closing of the Offering. The conversion price is the lower of (a) 80% of the Offering price per share and (b) the valuation of the Issuer immediately prior to the closing of the Offering divided by the number of fully diluted shares of capital stock (on an as-converted basis) outstanding immediately prior to Offering, excluding the Convertible Notes.

Read SEC document
May 11, 2026 Filed May 12, 2026 01:36 UTC Mobia Medical, Inc. MOBI · Entity 5669 ConversionCommon Stock 476,485 Not disclosed Not disclosed
Disclosure

SEC source: 0001628280-26-033804 · wk-form4_1778549766.xml · nonDerivative · entry 5

Curnes Nelson Bunker · CIK 0002124944 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Indirect · By Exceller Hunt Microtransponder 2017, LP

Disclosed balance after: 476,485

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each share of the Series A, Series C, Series D, Series E-1, Series E-2 and Series F Preferred Stock converted into Common Stock immediately prior to the completion of the Issuer's initial public offering (the "Offering") pursuant to its terms.

Read SEC document
May 11, 2026 Filed May 12, 2026 01:36 UTC Mobia Medical, Inc. MOBI · Entity 5669 ConversionCommon Stock 5,742 Not disclosed Not disclosed
Disclosure

SEC source: 0001628280-26-033804 · wk-form4_1778549766.xml · nonDerivative · entry 4

Curnes Nelson Bunker · CIK 0002124944 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Indirect · By Family Trusts

Disclosed balance after: 5,742

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each share of the Series A, Series C, Series D, Series E-1, Series E-2 and Series F Preferred Stock converted into Common Stock immediately prior to the completion of the Issuer's initial public offering (the "Offering") pursuant to its terms.

Read SEC document
May 11, 2026 Filed May 12, 2026 01:36 UTC Mobia Medical, Inc. MOBI · Entity 5669 Tax withholdingCommon Stock 13,368 $15.00 $200,520.00
Disclosure

SEC source: 0001628280-26-033804 · wk-form4_1778549766.xml · nonDerivative · entry 3

Curnes Nelson Bunker · CIK 0002124944 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 303,638

Read SEC document
May 11, 2026 Filed May 12, 2026 01:36 UTC Mobia Medical, Inc. MOBI · Entity 5669 OtherCommon Stock 13,684 $14.65 $200,511.65
Disclosure

SEC source: 0001628280-26-033804 · wk-form4_1778549766.xml · nonDerivative · entry 2

Curnes Nelson Bunker · CIK 0002124944 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 317,006

Read SEC document
May 11, 2026 Filed May 12, 2026 01:36 UTC Mobia Medical, Inc. MOBI · Entity 5669 ConversionCommon Stock 283,895 Not disclosed Not disclosed
Disclosure

SEC source: 0001628280-26-033804 · wk-form4_1778549766.xml · nonDerivative · entry 1

Curnes Nelson Bunker · CIK 0002124944 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 303,322

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each share of the Series A, Series C, Series D, Series E-1, Series E-2 and Series F Preferred Stock converted into Common Stock immediately prior to the completion of the Issuer's initial public offering (the "Offering") pursuant to its terms.

Read SEC document
May 07, 2026 Filed May 12, 2026 01:36 UTC Mobia Medical, Inc. MOBI · Entity 5669 GrantStock Option · Derivative 206,070 $0.00 Strike: $15.00 $0.00
Disclosure

SEC source: 0001628280-26-033804 · wk-form4_1778549766.xml · derivative · entry 11

Curnes Nelson Bunker · CIK 0002124944 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 206,070

Underlying: Common Stock · 206,070 shares

Expires 2036-05-07

F4 · derivative.exercise_date: The stock option will vest as to 25% of the underlying shares on May 7, 2027, and will vest thereafter in 36 substantially equal monthly installments.

Read SEC document
February 23, 2026 Filed Jun 11, 2026 23:10 UTC Mobia Medical, Inc. MOBI · Entity 5669 OtherCommon Stock 175,077 $0.00 $0.00
Disclosure

SEC source: 0001193125-26-268109 · ownership.xml · nonDerivative · entry 2

Curnes Nelson Bunker · CIK 0002124944 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Indirect · By Curnes Fund 2001

Disclosed balance after: 0

F1 · date: This transaction occurred prior to the Issuer's registration of a class of equity securities under Section 12 of the Securities Exchange Act of 1934, as amended, in connection with the Issuer's initial public offering and is reported pursuant to Rule 16a-2(a).

F2 · kind: Prior to the Issuer's initial public offering on May 7, 2026, the Curnes Fund 2001 and the Exceller Hunt Microtransponder 2017, LP distributed 175,077 and 249,750 shares of the Issuer's common stock, respectively, to their members (the "Distributions"). The Reporting Person received 58,359 shares of common stock in the Distributions. The Reporting Person's prior Form 3, dated May 7, 2026 and Form 4, dated May 11, 2026, inadvertently reported ownership prior to the Distributions. This Form 4 has been updated to reflect the Reporting Person's ownership following the Distributions. All shares in the Distributions remain subject to the lock-up restrictions implemented in connection with the initial public offering.

Read SEC document
February 23, 2026 Filed Jun 11, 2026 23:10 UTC Mobia Medical, Inc. MOBI · Entity 5669 OtherCommon Stock 249,750 $0.00 $0.00
Disclosure

SEC source: 0001193125-26-268109 · ownership.xml · nonDerivative · entry 1

Curnes Nelson Bunker · CIK 0002124944 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Indirect · By Exceller Hunt Microtransponder 2017, LP

Disclosed balance after: 560,068

F1 · date: This transaction occurred prior to the Issuer's registration of a class of equity securities under Section 12 of the Securities Exchange Act of 1934, as amended, in connection with the Issuer's initial public offering and is reported pursuant to Rule 16a-2(a).

F2 · kind: Prior to the Issuer's initial public offering on May 7, 2026, the Curnes Fund 2001 and the Exceller Hunt Microtransponder 2017, LP distributed 175,077 and 249,750 shares of the Issuer's common stock, respectively, to their members (the "Distributions"). The Reporting Person received 58,359 shares of common stock in the Distributions. The Reporting Person's prior Form 3, dated May 7, 2026 and Form 4, dated May 11, 2026, inadvertently reported ownership prior to the Distributions. This Form 4 has been updated to reflect the Reporting Person's ownership following the Distributions. All shares in the Distributions remain subject to the lock-up restrictions implemented in connection with the initial public offering.

Read SEC document
February 05, 2026 Filed May 12, 2026 01:36 UTC Mobia Medical, Inc. MOBI · Entity 5669 GrantConvertible Notes · Derivative 100,937.62 $100,937.62 $10,188,403,131.26
Disclosure

SEC source: 0001628280-26-033804 · wk-form4_1778549766.xml · derivative · entry 10

Curnes Nelson Bunker · CIK 0002124944 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Indirect · By Curnes Fund 2001

Disclosed balance after: 2,100,937.62

Underlying: Common Stock · 8,411 shares

Expires not disclosed

F2 · derivative.exercise_price: The Convertible Notes automatically converted into Common Stock immediately prior to the closing of the Offering. The conversion price is the lower of (a) 80% of the Offering price per share and (b) the valuation of the Issuer immediately prior to the closing of the Offering divided by the number of fully diluted shares of capital stock (on an as-converted basis) outstanding immediately prior to Offering, excluding the Convertible Notes.

F3 · date: This transaction occurred prior to the Issuer's registration of a class of equity securities under Section 12 of the Securities Exchange Act of 1934, as amended, in connection with the Offering, and is reported herein pursuant to Rule 16a-2(a).

F2 · derivative.exercise_date: The Convertible Notes automatically converted into Common Stock immediately prior to the closing of the Offering. The conversion price is the lower of (a) 80% of the Offering price per share and (b) the valuation of the Issuer immediately prior to the closing of the Offering divided by the number of fully diluted shares of capital stock (on an as-converted basis) outstanding immediately prior to Offering, excluding the Convertible Notes.

F2 · derivative.expiration_date: The Convertible Notes automatically converted into Common Stock immediately prior to the closing of the Offering. The conversion price is the lower of (a) 80% of the Offering price per share and (b) the valuation of the Issuer immediately prior to the closing of the Offering divided by the number of fully diluted shares of capital stock (on an as-converted basis) outstanding immediately prior to Offering, excluding the Convertible Notes.

Read SEC document
January 30, 2026 Filed May 12, 2026 01:36 UTC Mobia Medical, Inc. MOBI · Entity 5669 GrantConvertible Notes · Derivative 4,000,000 $4,000,000.00 $16,000,000,000,000.00
Disclosure

SEC source: 0001628280-26-033804 · wk-form4_1778549766.xml · derivative · entry 9

Curnes Nelson Bunker · CIK 0002124944 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Indirect · By Exceller Hunt Microtransponder 2017, LP

Disclosed balance after: 4,000,000

Underlying: Common Stock · 333,333 shares

Expires not disclosed

F2 · derivative.exercise_price: The Convertible Notes automatically converted into Common Stock immediately prior to the closing of the Offering. The conversion price is the lower of (a) 80% of the Offering price per share and (b) the valuation of the Issuer immediately prior to the closing of the Offering divided by the number of fully diluted shares of capital stock (on an as-converted basis) outstanding immediately prior to Offering, excluding the Convertible Notes.

F3 · date: This transaction occurred prior to the Issuer's registration of a class of equity securities under Section 12 of the Securities Exchange Act of 1934, as amended, in connection with the Offering, and is reported herein pursuant to Rule 16a-2(a).

F2 · derivative.exercise_date: The Convertible Notes automatically converted into Common Stock immediately prior to the closing of the Offering. The conversion price is the lower of (a) 80% of the Offering price per share and (b) the valuation of the Issuer immediately prior to the closing of the Offering divided by the number of fully diluted shares of capital stock (on an as-converted basis) outstanding immediately prior to Offering, excluding the Convertible Notes.

F2 · derivative.expiration_date: The Convertible Notes automatically converted into Common Stock immediately prior to the closing of the Offering. The conversion price is the lower of (a) 80% of the Offering price per share and (b) the valuation of the Issuer immediately prior to the closing of the Offering divided by the number of fully diluted shares of capital stock (on an as-converted basis) outstanding immediately prior to Offering, excluding the Convertible Notes.

Read SEC document
January 30, 2026 Filed May 12, 2026 01:36 UTC Mobia Medical, Inc. MOBI · Entity 5669 GrantConvertible Notes · Derivative 2,000,000 $2,000,000.00 $4,000,000,000,000.00
Disclosure

SEC source: 0001628280-26-033804 · wk-form4_1778549766.xml · derivative · entry 8

Curnes Nelson Bunker · CIK 0002124944 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Indirect · By Curnes Fund 2001

Disclosed balance after: 2,000,000

Underlying: Common Stock · 166,666 shares

Expires not disclosed

F2 · derivative.exercise_price: The Convertible Notes automatically converted into Common Stock immediately prior to the closing of the Offering. The conversion price is the lower of (a) 80% of the Offering price per share and (b) the valuation of the Issuer immediately prior to the closing of the Offering divided by the number of fully diluted shares of capital stock (on an as-converted basis) outstanding immediately prior to Offering, excluding the Convertible Notes.

F3 · date: This transaction occurred prior to the Issuer's registration of a class of equity securities under Section 12 of the Securities Exchange Act of 1934, as amended, in connection with the Offering, and is reported herein pursuant to Rule 16a-2(a).

F2 · derivative.exercise_date: The Convertible Notes automatically converted into Common Stock immediately prior to the closing of the Offering. The conversion price is the lower of (a) 80% of the Offering price per share and (b) the valuation of the Issuer immediately prior to the closing of the Offering divided by the number of fully diluted shares of capital stock (on an as-converted basis) outstanding immediately prior to Offering, excluding the Convertible Notes.

F2 · derivative.expiration_date: The Convertible Notes automatically converted into Common Stock immediately prior to the closing of the Offering. The conversion price is the lower of (a) 80% of the Offering price per share and (b) the valuation of the Issuer immediately prior to the closing of the Offering divided by the number of fully diluted shares of capital stock (on an as-converted basis) outstanding immediately prior to Offering, excluding the Convertible Notes.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.